By expenditures
| Name | Title | Type |
|---|---|---|
| Rhen Bass | Chief Executive Officer | Auditee |
| Rich Larsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 404911 | 2025 | 2026-06-25 | NOVOGRADAC & COMPANY LLP | $55.78M |
| 355783 | 2024 | 2025-05-07 | Novogradac & Company LLP | $54.47M |
| 314608 | 2023 | 2024-07-08 | Novogradac & Company LLP | $38.84M |
| 51712 | 2022 | 2023-06-29 | Novogradac & Company LLP | $29.39M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 404911 | 2025 | 2026-06-25 | 1218821 | 2025-003 | Material Weakness | Yes | N |
| 404911 | 2025 | 2026-06-25 | 1218820 | 2025-002 | Material Weakness | Yes | E |
| 404911 | 2025 | 2026-06-25 | 1218819 | 2025-003 | Material Weakness | Yes | N |
| 404911 | 2025 | 2026-06-25 | 1218818 | 2025-002 | Material Weakness | Yes | E |
| 355783 | 2024 | 2025-05-07 | 1136283 | 2024-001 | Significant Deficiency | Yes | N |
| 355783 | 2024 | 2025-05-07 | 1136282 | 2024-001 | Significant Deficiency | Yes | N |
| 355783 | 2024 | 2025-05-07 | 559841 | 2024-001 | Significant Deficiency | Yes | N |
| 355783 | 2024 | 2025-05-07 | 559840 | 2024-001 | Significant Deficiency | Yes | N |
| 314608 | 2023 | 2024-07-08 | 1054354 | 2023-001 | Significant Deficiency | Yes | N |
| 314608 | 2023 | 2024-07-08 | 477912 | 2023-001 | Significant Deficiency | Yes | N |
| 51712 | 2022 | 2023-06-29 | 618731 | 2022-001 | Significant Deficiency | - | N |
| 51712 | 2022 | 2023-06-29 | 42289 | 2022-001 | Significant Deficiency | - | N |